BLOOMCHEMAG
BLOOMCHEMAG has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €550k and a net result of €89k. Equity is growing by ~52.7% per year across the filed fiscal years. Its solvency ranks better than 22% of 7779 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
| Equity | €550k |
| Net result | €89k |
| Better than sector | 22% |
| Active | 12 yrs |
Strong profile, led by stability.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 16.1% | 44.6% | |
| Net result | €89k | €31k | |
| Equity | €550k | €395k | |
| Gross operating margin | €132k | €210k | |
| Total assets | €3.43M | €1.07M |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | abbreviated schema | abbreviated schema | abbreviated schema | abbreviated schema | abbreviated schema |
| Revenue | €12.69M | €12.67M | €9.06M | €8.54M | €7.39M |
| EBITDA | €124k | €201k | - | - | - |
| Net profit | €89k | €145k | €116k | €70k | €45k |
| Cash flow | €93k | €146k | - | - | - |
| Staff costs | - | - | - | - | - |
| Income taxes | €30k | €49k | €39k | €26k | €38k |
| Dividends | - | - | - | - | - |
| Total assets | €3.43M | €2.32M | €2.16M | €1.63M | €1.17M |
| Equity | €550k | €461k | €316k | €200k | €130k |
| Debt | €2.88M | €1.86M | €1.85M | €1.43M | €1.04M |
| of which ≤ 1y | €2.88M | €1.86M | €1.85M | €1.43M | €1.04M |
| of which > 1y | - | - | - | - | - |
| Working capital | €533k | €439k | €316k | €200k | €130k |
| Employees (FTE) | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 1.19 | 1.24 | 1.17 | 1.14 | 1.13 |
| Quick ratio | 0.61 | 0.31 | 0.40 | 0.63 | 0.54 |
| Working capital ratio | 15.6% | 18.9% | 14.6% | 12.2% | 11.1% |
| Solvency | 16.1% | 19.9% | 14.6% | 12.2% | 11.1% |
| Debt / equity | 5.23 | 4.02 | 5.84 | 7.16 | 7.99 |
| Long-term debt ratio | - | - | - | - | - |
| Interest coverage | 10.47 | 19.34 | - | - | - |
| Gross margin | 0.9% | 1.5% | 2.3% | 1.4% | 1.4% |
| Net margin | 0.7% | 1.1% | 1.3% | 0.8% | 0.6% |
| ROA | 2.6% | 6.3% | 5.4% | 4.3% | 3.9% |
| ROE | 16.1% | 31.5% | 36.8% | 35.1% | 34.9% |
| EBITDA margin | 1.0% | 1.6% | - | - | - |
| Days sales outstanding | 40d | 7d | 17d | 12d | 11d |
| Days payable outstanding | 82d | 53d | 72d | 60d | 49d |
| Inventory turnover | 7.60 | 7.26 | 6.24 | 11.49 | 11.94 |
| Days inventory (DSI) | 48d | 50d | 58d | 32d | 31d |
Full annual accounts (23 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €3.43M | €2.32M | €2.16M | €1.63M | €1.17M |
| Fixed assets | 21/28 | €18k | €22k | - | - | - |
| Intangible fixed assets | 21 | €18k | €22k | - | - | - |
| Current assets | 29/58 | €3.41M | €2.30M | €2.16M | €1.63M | €1.17M |
| Stocks & contracts in progress | 3 | €1.65M | €1.72M | €1.42M | €732k | €610k |
| Amounts receivable within one year | 40/41 | €1.42M | €232k | €464k | €315k | €263k |
| Cash & bank | 54/58 | €333k | €342k | €277k | €581k | €293k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €3.43M | €2.32M | €2.16M | €1.63M | €1.17M |
| Equity | 10/15 | €550k | €461k | €316k | €200k | €130k |
| Contributions / capital | 10/11 | €7k | €7k | €7k | €7k | €7k |
| Reserves | 13 | €543k | €454k | €309k | €192k | €122k |
| Amounts payable | 17/49 | €2.88M | €1.86M | €1.85M | €1.43M | €1.04M |
| Amounts payable within one year | 42/48 | €2.88M | €1.86M | €1.85M | €1.43M | €1.04M |
| Trade debts payable within one year | 44 | €2.82M | €1.81M | €1.75M | €1.38M | €984k |
| Income statement | ||||||
| Turnover | 70 | €12.69M | €12.67M | €9.06M | €8.54M | €7.39M |
| Gross operating margin | 9900 | €132k | €203k | €208k | €122k | €107k |
| Operating result | 9901 | €120k | €201k | €204k | €122k | €106k |
| Financial income | 75 | €10k | €3k | €2k | €9k | €14k |
| Financial charges | 65 | €12k | €10k | €51k | €35k | €37k |
| Result before taxes | 9903 | €118k | €194k | €156k | €96k | €83k |
| Income taxes | 67/77 | €30k | €49k | €39k | €26k | €38k |
| Net result for the period | 9904 | €89k | €145k | €116k | €70k | €45k |
| Result to be appropriated | 9905 | €89k | €145k | €116k | €70k | €45k |
| NACE primary | Wholesale of industrial chemicals(46851) |
| Legal form | Private limited company(610) |
| Incorporation | 21-01-2014 |
| Status | Active |
| Postal code | 2400 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13432B0353/00R003 | Flanders | 993 m² | 1 · 201 m² | 12.1 m · 3 fl. |
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
| Legal nameNL | BLOOMCHEMAG |